Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan
NCT02335606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 213
Last updated 2022-01-21
Summary
Abatacept Registry in Taiwan
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-06
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis
NCT03457792 ·Status: COMPLETED
-
A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)
NCT03505892 ·Status: COMPLETED
-
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
NCT02778906 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00503503 ·Status: COMPLETED
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT01188655 ·Status: COMPLETED
-
Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics
NCT01166620 ·Status: COMPLETED
-
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
NCT02489760 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00256919 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
NCT02486302 ·Status: COMPLETED
-
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
NCT04343378 ·Status: COMPLETED
-
Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept
NCT01221636 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
NCT00544557 ·Status: COMPLETED
-
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
NCT05421442 ·Status: COMPLETED
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
NCT03492658 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries
NCT02632890 ·Status: COMPLETED
-
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
NCT00244556 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
NCT00503139 ·Status: COMPLETED
-
The Study of Abatacept in Combination With Etanercept
NCT00162279 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
NCT01299961 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
NCT00252668 ·Status: COMPLETED ·Phase: PHASE4